A 6-Week Randomised, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy of Lurasidone Adjunctive Therapy in Improving Cognitive Functioning in Euthymic Bipolar Disorder Patients (ELICE-BD)
Phase of Trial: Phase III
Latest Information Update: 29 Jun 2017
At a glance
- Drugs Lurasidone (Primary)
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- Acronyms ELICE-BD
- 08 May 2017 Status changed from not yet recruiting to recruiting.
- 31 Oct 2016 Planned initiation date changed from 1 Jul 2016 to 1 Nov 2016.
- 12 Jul 2016 Planned initiation date changed from 1 Jun 2016 to 1 Jul 2016.